Flow Cytometry Panel-Reactive Antibody Screening of Anti-HLA Antibodies in the Waiting List Significantly Reduces the Occurrence of Acute Rejection After Kidney Transplantation.

•The occurrence of acute rejection upon implementing the screening was reduced in our transplant center from 44% to 19 % (P < .0001).•The only predictor for development of acute rejection in the monitored period of 12 months was the delayed graft function.•No difference was recorded in the 12-month survival of grafts and patients according to the applied induction immunosuppressive protocol.